Loading...
Malignancy and IFITM3: Friend or Foe?
The prevalence and incidence of cancers has risen over the last decade. Available treatments have improved outcomes, yet mortality and morbidity remain high, creating an urgent demand for personalized and new therapy targets. Interferon induced transmembrane protein (IFITM3) is highly expressed in c...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753217/ https://ncbi.nlm.nih.gov/pubmed/33364194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.593245 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|